1-3 of 3
Virginie de Beco
Close
Sort by
Journal Articles

Final Results of a Phase 1 Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Myelofibrosis ( FLT-MF-2009 Study)

Annalisa Andreoli, MD, Laetitia Vercellino, MD, Matthieu John Ouvrier, MD, Emmanuelle Barré, PharmD, Bruno Cassinat, PharmD, PhD, Virginie de Beco, PharmD, Pascal Merlet, MD PhD, Christine Dosquet, MD PhD, Christine Chomienne, MD PhD, Sylvie Chevret, MD PhD, Marie-Elisabeth Toubert, MD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3195.
https://doi.org/10.1182/blood.V124.21.3195.3195
Published: 2014
Journal Articles

18 F-FLT Positron Emission Tomography (PET)/CT Imaging in Myelofibrosis: A Non Invasive Method to Assess Bone Marrow Function and Extramedullary Hematopoiesis

Annalisa Andreoli, MD, Laetitia Vercellino, Mathieu-John Ouvrier, Emmanuelle Barré, Bruno Cassinat, PharmD, PhD, Virginie de Beco, Jean-Marc Zini, MD, PhD, Pascal Merlet, MD, Christine Dosquet, MD, Christine Chomienne, MD, PhD, Marie-Elisabeth Toubert, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1741.
https://doi.org/10.1182/blood.V120.21.1741.1741
Published: 2012
Journal Articles

Is There a Role for Red Cell Mass (RCM) Assessment To Classify Myeloproliferative Disorders (MPD) in the JAK2 Era?.

Bruno Cassinat, PharmD, Christelle Laguillier, PharmD, Claude Gardin, MD, Virginie De Beco, MD, Sara Burcheri, MD, Pierre Fenaux, MD, PhD, Christine Chomienne, MD, PhD, Jean-Jacques Kiladjian, MD
Journal: Blood
Blood (2007) 110 (11): 4633.
https://doi.org/10.1182/blood.V110.11.4633.4633
Published: 2007